SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 9 filers reported holding SEAGEN INC in Q4 2023. The put-call ratio across all filers is 0.99 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $693,731 | +10.4% | 3,270 | +0.2% | 0.09% | +15.4% |
| Q2 2023 | $628,382 | -8.4% | 3,265 | -3.7% | 0.08% | -16.1% |
| Q1 2023 | $686,373 | +50.2% | 3,390 | -4.6% | 0.09% | +34.8% |
| Q4 2022 | $456,853 | -6.0% | 3,555 | 0.0% | 0.07% | -14.8% |
| Q3 2022 | $486,000 | +12.2% | 3,555 | +45.4% | 0.08% | +15.7% |
| Q2 2022 | $433,000 | +34.5% | 2,445 | +9.4% | 0.07% | +52.2% |
| Q1 2022 | $322,000 | +25.3% | 2,235 | +34.6% | 0.05% | +9.5% |
| Q4 2021 | $257,000 | -8.9% | 1,660 | 0.0% | 0.04% | -36.4% |
| Q3 2021 | $282,000 | +7.6% | 1,660 | 0.0% | 0.07% | +8.2% |
| Q2 2021 | $262,000 | +13.4% | 1,660 | 0.0% | 0.06% | -6.2% |
| Q1 2021 | $231,000 | -20.6% | 1,660 | 0.0% | 0.06% | -27.0% |
| Q4 2020 | $291,000 | – | 1,660 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
| Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
| Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
| PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
| Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
| Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
| Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
| Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
| Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |